Skip to Content
· Dermal Fillers
SKU 10970

Olidia 240

In stock
Volume
1 x 243,4 mg
Laboratory
PRP Life Science Co., Ltd.
Origin
South Korea
Indication
Overall facial lifting and skin elasticity improvement
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Olidia 240, also known as the Olidia 240 filler, is an injectable Poly-L-Lactic Acid (PLLA) based dermal filler by OLIDIA, manufactured by PRP Life Science Co., Ltd. in South Korea for overall facial lifting and skin elasticity improvement. It is commonly used by licensed practitioners and clinics for facial contour support in the cheeks, nasolabial folds and jawline. The formulation contains PLLA, CMC and mannitol at a dose of 243.4 mg per vial, and is intended for professional use.

Key Benefits of Olidia 240

  • Supports overall lifting and skin elasticity
  • Helps improve firmness in areas affected by laxity
  • Suitable for cheeks, nasolabial folds, and jawline contouring
  • Promotes gradual collagen regeneration
  • Provides progressive, natural-looking improvement
  • CE-marked for professional aesthetic use
Key Information
Brand OLIDIA
Manufacturer PRP Life Science Co., Ltd.
Country of Origin South Korea
Certification CE-marked
Ingredients Poly-L-Lactic Acid (PLLA), Carboxymethylcellulose (CMC), Mannitol
Concentration 243.4 mg PLLA per vial
Volume / Size 1 vial x 243.4 mg
Packaging 1 vial x 243.4 mg
Use Type Professional use only - licensed practitioner administration
Injection Depth Subdermal

Indications and Professional Use

Main indications

  • Overall facial lifting
  • Loss of elasticity
  • Facial contour support
  • Subdermal collagen-stimulation protocols

Professional use

For professional use only, by licensed medical practitioners trained in biostimulatory injectable technique. Olidia 240 is intended for subdermal injection to support overall facial lifting, skin elasticity, and contour in the cheeks, nasolabial folds and jawline, in accordance with the product's technical documentation. Anaesthetic content:. Contraindications:.

Treatment areas

  • Cheeks
  • Nasolabial folds
  • Jawline

Patient profile

Suitable for adult patients following clinical assessment by the treating practitioner, for gradual collagen-driven lifting and firmness in areas affected by laxity. Patient selection, including contraindications and precautions, must be determined per the manufacturer's Instructions for Use:.

How Olidia 240 Works

Olidia 240 works through Poly-L-Lactic Acid (PLLA) at a dose of 243.4 mg, combined with CMC and mannitol, injected into the subdermal layer to stimulate gradual collagen regeneration. This supports overall facial lifting, improved elasticity, and firmness in the cheeks, nasolabial folds and jawline, with progressive, natural-looking results over time.

Why Order From Allpara

Allpara offers genuine, verified OLIDIA products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions

What is Olidia 240 used for?

Olidia 240 is used for overall facial lifting and skin elasticity improvement, supporting facial contour in the cheeks, nasolabial folds and jawline.

What is in the Olidia 240 filler?

The Olidia 240 filler contains Poly-L-Lactic Acid (PLLA), carboxymethylcellulose (CMC), and mannitol, at a dose of 243.4 mg per vial.

How is Olidia 240 different from Olidia 365?

Olidia 240 (243.4 mg PLLA per vial) is designed for overall lifting and elasticity in the cheeks, nasolabial folds and jawline, while Olidia 365 is a separate, higher-dose product in the same range. Duration and indication details differ by dose variant and should be confirmed against each product's own documentation.

What injection depth is Olidia 240 designed for?

Olidia 240 is designed for injection into the subdermal layer.

Does Allpara provide batch documentation for Olidia 240?

Yes. Allpara can provide batch traceability records and certificates on request to registered clinics and distributors.

/ Specifications

The datasheet

Category
Dermal Fillers
Brand
OLIDIA
Laboratory
PRP Life Science Co., Ltd.
SKU
10970
Format
1 x 243,4 mg
Origin
South Korea
Indication
Overall facial lifting and skin elasticity improvement
Use
Professional / clinical biostimulatory injection
/ Product details

The full file

Olidia 240, also known as the Olidia 240 filler, is an injectable Poly-L-Lactic Acid (PLLA) based dermal filler by OLIDIA, manufactured by PRP Life Science Co., Ltd. in South Korea for overall facial lifting and skin elasticity improvement. It is commonly used by licensed practitioners and clinics for facial contour support in the cheeks, nasolabial folds and jawline. The formulation contains PLLA, CMC and mannitol at a dose of 243.4 mg per vial, and is intended for professional use.

PRP Life Science Co., Ltd., country of origin South Korea.

Shipped EU-wide from our EU warehouse, tracked and insured, with 24-72h dispatch. Each unit ships with batch number and expiry, held in EU bond and batch-traceable.

Store to manufacturer specification, away from direct light. Cold-chain is only used where the product requires it.

Net 30 / 60 / 90 day terms* are available to verified accounts on credit approval. Invoicing is supported in EUR, CHF and GBP.

Terms are indicative and confirmed after account review.

What is Olidia 240 used for?

Olidia 240 is used for overall facial lifting and skin elasticity improvement, supporting facial contour in the cheeks, nasolabial folds and jawline.

What is in the Olidia 240 filler?

The Olidia 240 filler contains Poly-L-Lactic Acid (PLLA), carboxymethylcellulose (CMC), and mannitol, at a dose of 243.4 mg per vial.

How is Olidia 240 different from Olidia 365?

Olidia 240 (243.4 mg PLLA per vial) is designed for overall lifting and elasticity in the cheeks, nasolabial folds and jawline, while Olidia 365 is a separate, higher-dose product in the same range. Duration and indication details differ by dose variant and should be confirmed against each product's own documentation.

What injection depth is Olidia 240 designed for?

Olidia 240 is designed for injection into the subdermal layer.

Does Allpara provide batch documentation for Olidia 240?

Yes. Allpara can provide batch traceability records and certificates on request to registered clinics and distributors.

/ Quick answers

Everything a buyer asks first

What is Olidia 240 used for?
Olidia 240 is used for overall facial lifting and skin elasticity improvement, supporting facial contour in the cheeks, nasolabial folds and jawline.
What is in the Olidia 240 filler?
The Olidia 240 filler contains Poly-L-Lactic Acid (PLLA), carboxymethylcellulose (CMC), and mannitol, at a dose of 243.4 mg per vial.
How is Olidia 240 different from Olidia 365?
Olidia 240 (243.4 mg PLLA per vial) is designed for overall lifting and elasticity in the cheeks, nasolabial folds and jawline, while Olidia 365 is a separate, higher-dose product in the same range. Duration and indication details differ by dose variant and should be confirmed against each product's own documentation.
/ FAQ

Frequently asked

Olidia 240 is used for overall facial lifting and skin elasticity improvement, supporting facial contour in the cheeks, nasolabial folds and jawline.
The Olidia 240 filler contains Poly-L-Lactic Acid (PLLA), carboxymethylcellulose (CMC), and mannitol, at a dose of 243.4 mg per vial.
Olidia 240 (243.4 mg PLLA per vial) is designed for overall lifting and elasticity in the cheeks, nasolabial folds and jawline, while Olidia 365 is a separate, higher-dose product in the same range. Duration and indication details differ by dose variant and should be confirmed against each product's own documentation.
Olidia 240 is designed for injection into the subdermal layer.
Yes. Allpara can provide batch traceability records and certificates on request to registered clinics and distributors.

More from PRP Life Science

View laboratory

Clinic alternatives

All products

Olidia 240

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Olidia 240, also known as the Olidia 240 filler, is an injectable Poly-L-Lactic Acid (PLLA) based dermal filler by OLIDIA, manufactured by PRP Life Science Co., Ltd. in South Korea for overall facial lifting and skin elasticity improvement. It is commonly used by licensed practitioners and clinics for facial contour support in the cheeks, nasolabial folds and jawline. The formulation contains PLLA, CMC and mannitol at a dose of 243.4 mg per vial, and is intended for professional use.

Key Benefits of Olidia 240

  • Supports overall lifting and skin elasticity
  • Helps improve firmness in areas affected by laxity
  • Suitable for cheeks, nasolabial folds, and jawline contouring
  • Promotes gradual collagen regeneration
  • Provides progressive, natural-looking improvement
  • CE-marked for professional aesthetic use
Key Information
Brand OLIDIA
Manufacturer PRP Life Science Co., Ltd.
Country of Origin South Korea
Certification CE-marked
Ingredients Poly-L-Lactic Acid (PLLA), Carboxymethylcellulose (CMC), Mannitol
Concentration 243.4 mg PLLA per vial
Volume / Size 1 vial x 243.4 mg
Packaging 1 vial x 243.4 mg
Use Type Professional use only - licensed practitioner administration
Injection Depth Subdermal

Indications and Professional Use

Main indications

  • Overall facial lifting
  • Loss of elasticity
  • Facial contour support
  • Subdermal collagen-stimulation protocols

Professional use

For professional use only, by licensed medical practitioners trained in biostimulatory injectable technique. Olidia 240 is intended for subdermal injection to support overall facial lifting, skin elasticity, and contour in the cheeks, nasolabial folds and jawline, in accordance with the product's technical documentation. Anaesthetic content:. Contraindications:.

Treatment areas

  • Cheeks
  • Nasolabial folds
  • Jawline

Patient profile

Suitable for adult patients following clinical assessment by the treating practitioner, for gradual collagen-driven lifting and firmness in areas affected by laxity. Patient selection, including contraindications and precautions, must be determined per the manufacturer's Instructions for Use:.

How Olidia 240 Works

Olidia 240 works through Poly-L-Lactic Acid (PLLA) at a dose of 243.4 mg, combined with CMC and mannitol, injected into the subdermal layer to stimulate gradual collagen regeneration. This supports overall facial lifting, improved elasticity, and firmness in the cheeks, nasolabial folds and jawline, with progressive, natural-looking results over time.

Why Order From Allpara

Allpara offers genuine, verified OLIDIA products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.

Frequently Asked Questions

What is Olidia 240 used for?

Olidia 240 is used for overall facial lifting and skin elasticity improvement, supporting facial contour in the cheeks, nasolabial folds and jawline.

What is in the Olidia 240 filler?

The Olidia 240 filler contains Poly-L-Lactic Acid (PLLA), carboxymethylcellulose (CMC), and mannitol, at a dose of 243.4 mg per vial.

How is Olidia 240 different from Olidia 365?

Olidia 240 (243.4 mg PLLA per vial) is designed for overall lifting and elasticity in the cheeks, nasolabial folds and jawline, while Olidia 365 is a separate, higher-dose product in the same range. Duration and indication details differ by dose variant and should be confirmed against each product's own documentation.

What injection depth is Olidia 240 designed for?

Olidia 240 is designed for injection into the subdermal layer.

Does Allpara provide batch documentation for Olidia 240?

Yes. Allpara can provide batch traceability records and certificates on request to registered clinics and distributors.

More from PRP Life Science

View laboratory →

Olidia 240, also known as the Olidia 240 filler, is an injectable Poly-L-Lactic Acid (PLLA) based dermal filler by OLIDIA, manufactured by PRP Life Science Co., Ltd. in South Korea for overall facial lifting and skin elasticity improvement. It is commonly used by licensed practitioners and clinics for facial contour support in the cheeks, nasolabial folds and jawline. The formulation contains PLLA, CMC and mannitol at a dose of 243.4 mg per vial, and is intended for professional use.

PRP Life Science Co., Ltd., country of origin South Korea.

Shipped EU-wide from our EU warehouse, 24-72h dispatch, tracked and insured. Each unit ships with batch number and expiry, held in EU bond and batch-traceable. Store to manufacturer specification.

Net 30 / 60 / 90 day terms* for verified accounts on credit approval. Invoicing in EUR, CHF and GBP.

What is Olidia 240 used for?

Olidia 240 is used for overall facial lifting and skin elasticity improvement, supporting facial contour in the cheeks, nasolabial folds and jawline.

What is in the Olidia 240 filler?

The Olidia 240 filler contains Poly-L-Lactic Acid (PLLA), carboxymethylcellulose (CMC), and mannitol, at a dose of 243.4 mg per vial.

How is Olidia 240 different from Olidia 365?

Olidia 240 (243.4 mg PLLA per vial) is designed for overall lifting and elasticity in the cheeks, nasolabial folds and jawline, while Olidia 365 is a separate, higher-dose product in the same range. Duration and indication details differ by dose variant and should be confirmed against each product's own documentation.

What injection depth is Olidia 240 designed for?

Olidia 240 is designed for injection into the subdermal layer.

Does Allpara provide batch documentation for Olidia 240?

Yes. Allpara can provide batch traceability records and certificates on request to registered clinics and distributors.

* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.